New triple antiviral drug combination shows promise for treating COVID-19
Phase 2 randomized trial shows early treatment with triple antiviral therapy is safe and shortens duration of viral shedding in patients with mild to moderate COVID-19. …
Phase 2 randomized trial shows early treatment with triple antiviral therapy is safe and shortens duration of viral shedding in patients with mild to moderate COVID-19. …
New modeling of the virus’ behavior suggests that an intervention strategy based on shield immunity could reduce the risk of allowing the higher levels of human interaction …
A new study found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries. …
Results from 29 Italian patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation indicate that high-dose of the rheumatoid arthritis drug anakinra may show promise. …
Clinicians from two hospitals in Boston report that the majority of even the sickest patients with COVID-19 get better when they receive existing guideline-supported treatment for respiratory failure. …
In mice, rats, and nonhuman primates, a newly developed SARS-CoV-2 virus vaccine candidate induced antibodies that neutralized several different SARS-CoV-2 strains. …
New report highlights the potential health risk of SARS-CoV-2 in wastewater. …
Researchers have tested several methods for disinfecting N95 mask materials, finding that heating them preserves their filtration efficiency for 50 cycles of disinfection. …
A consortium of scientists with expertise in big data research and epidemiology recently developed a COVID Symptom Tracker app aimed at rapidly collecting information to aid in the response to the ongoing COVID-19 pandemic. …
Most patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells but the immune responses of different patients are not all the same. …
End of content
End of content